Rajendra Singh, Ji Yeon Kim, Eric F Glassy, Rajesh C Dash, Victor Brodsky, Jansen Seheult, M E Doc de Baca, Qiangqiang Gu, Shannon Hoekstra, Bobbi S Pritt
{"title":"Introduction to Generative Artificial Intelligence: Contextualizing the Future.","authors":"Rajendra Singh, Ji Yeon Kim, Eric F Glassy, Rajesh C Dash, Victor Brodsky, Jansen Seheult, M E Doc de Baca, Qiangqiang Gu, Shannon Hoekstra, Bobbi S Pritt","doi":"10.5858/arpa.2024-0221-RA","DOIUrl":null,"url":null,"abstract":"<p><strong>Context.—: </strong>Generative artificial intelligence (GAI) is a promising new technology with the potential to transform communication and workflows in health care and pathology. Although new technologies offer advantages, they also come with risks that users, particularly early adopters, must recognize. Given the fast pace of GAI developments, pathologists may find it challenging to stay current with the terminology, technical underpinnings, and latest advancements. Building this knowledge base will enable pathologists to grasp the potential risks and impacts that GAI may have on the future practice of pathology.</p><p><strong>Objective.—: </strong>To present key elements of GAI development, evaluation, and implementation in a way that is accessible to pathologists and relevant to laboratory applications.</p><p><strong>Data sources.—: </strong>Information was gathered from recent studies and reviews from PubMed and arXiv.</p><p><strong>Conclusions.—: </strong>GAI offers many potential benefits for practicing pathologists. However, the use of GAI in clinical practice requires rigorous oversight and continuous refinement to fully realize its potential and mitigate inherent risks. The performance of GAI is highly dependent on the quality and diversity of the training and fine-tuning data, which can also propagate biases if not carefully managed. Ethical concerns, particularly regarding patient privacy and autonomy, must be addressed to ensure responsible use. By harnessing these emergent technologies, pathologists will be well placed to continue forward as leaders in diagnostic medicine.</p>","PeriodicalId":93883,"journal":{"name":"Archives of pathology & laboratory medicine","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of pathology & laboratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5858/arpa.2024-0221-RA","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Context.—: Generative artificial intelligence (GAI) is a promising new technology with the potential to transform communication and workflows in health care and pathology. Although new technologies offer advantages, they also come with risks that users, particularly early adopters, must recognize. Given the fast pace of GAI developments, pathologists may find it challenging to stay current with the terminology, technical underpinnings, and latest advancements. Building this knowledge base will enable pathologists to grasp the potential risks and impacts that GAI may have on the future practice of pathology.
Objective.—: To present key elements of GAI development, evaluation, and implementation in a way that is accessible to pathologists and relevant to laboratory applications.
Data sources.—: Information was gathered from recent studies and reviews from PubMed and arXiv.
Conclusions.—: GAI offers many potential benefits for practicing pathologists. However, the use of GAI in clinical practice requires rigorous oversight and continuous refinement to fully realize its potential and mitigate inherent risks. The performance of GAI is highly dependent on the quality and diversity of the training and fine-tuning data, which can also propagate biases if not carefully managed. Ethical concerns, particularly regarding patient privacy and autonomy, must be addressed to ensure responsible use. By harnessing these emergent technologies, pathologists will be well placed to continue forward as leaders in diagnostic medicine.